Intravenous lidocaine infusion
Intravenous lidocaine infusion is a pharmaceutical drug with 5 clinical trials. Historical success rate of 75.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
75.0%
3 of 4 finished
25.0%
1 ended early
0
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Postoperative Analgesia in Patients Undergoing Percutaneous Nephrolithotomy
Intravenous Lidocaine Infusion Reduce Postoperative Pulmonary Complications in Patients Undergoing Minimally Invasive Esophagectomy
The Effect of Perioperative Intravenous Lidocaine Infusion on Opioid Consumption After Lumbar Spine Surgery
Local Anesthetic Continuous Preperitoneal Infiltration and Wound Hyperalgesia
Effect of Intravenous Lidocaine on BIS-guided Propofol Requirements During General Anesthesia
Clinical Trials (5)
Postoperative Analgesia in Patients Undergoing Percutaneous Nephrolithotomy
Intravenous Lidocaine Infusion Reduce Postoperative Pulmonary Complications in Patients Undergoing Minimally Invasive Esophagectomy
The Effect of Perioperative Intravenous Lidocaine Infusion on Opioid Consumption After Lumbar Spine Surgery
Local Anesthetic Continuous Preperitoneal Infiltration and Wound Hyperalgesia
Effect of Intravenous Lidocaine on BIS-guided Propofol Requirements During General Anesthesia
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5